Titel	Veröffentlichungsdatum	Sprache	Zitate
The Impact of Atrial Fibrillation on the Cost of Stroke: The Berlin Acute Stroke Study	2007/03/01	English	89
Utility Estimates for Decision–Analytic Modeling in Chronic Heart Failure—Health States Based on New York Heart Association Classes and Number of Rehospitalizations	2009/01/01	English	88
The Translation and Cultural Adaptation of Patient-Reported Outcome Measures	2005/03/01	English	88
Cost of Hypoglycemia in Patients with Type 2 Diabetes in Sweden	2006/05/01	English	87
Condition-Specific Preference-Based Measures: Benefit or Burden?	2012/05/01	English	87
Variation in Health Technology Assessment and Reimbursement Processes in Europe	2017/01/01	English	86
The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis	2009/01/01	English	86
The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review	2017/03/01	English	86
Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?	2010/12/01	English	85
Costs and Health Utilities Associated with Extremely Preterm Birth: Evidence from the EPICure Study	2009/11/01	English	85
Use of Pharmacoeconomics Information—Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health-Care Decision Making	2003/07/01	English	84
Does Attribute Framing in Discrete Choice Experiments Influence Willingness to Pay? Results from a Discrete Choice Experiment in Screening for Colorectal Cancer	2009/03/01	English	84
Assessing Productivity Loss and Activity Impairment in Severe or Difficult-to-Treat Asthma	2008/03/01	English	84
A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence	2011/06/01	English	84
The Time-Dependent Bias and its Effect on Extra Length of Stay due to Nosocomial Infection	2011/03/01	English	83
A Comparison of Methods for Analyzing Health-Related Quality-of-Life Measures	2002/07/01	English	83
A Review of Patient-Reported Outcome Labels in the United States: 2006 to 2010	2012/05/01	English	83
How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review	2011/09/01	English	83
Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population	2000/11/01	English	83
Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research—Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force	2015/03/01	English	83
Multicriteria Decision Analysis for Including Health Interventions in the Universal Health Coverage Benefit Package in Thailand	2012/09/01	English	83
Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study	2013/01/01	English	83
Value of Information Analysis for Research Decisions—An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force	2020/02/01	English	83
EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set	2019/01/01	English	82
Health State Valuations of Patients and the General Public Analytically Compared: A Meta-Analytical Comparison of Patient and Population Health State Utilities	2010/03/01	English	82
Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization	2010/06/01	English	82
Willingness to Pay for a Quality-Adjusted Life-Year: The Individual Perspective	2010/12/01	English	82
The Changing Face of the Cost-Utility Literature, 1990–2012	2015/03/01	English	82
Differences in Child versus Parent Reports of the Child's Health-Related Quality of Life in Children with Epilepsy and Healthy Siblings	2010/09/01	English	82
The Impact of Gout on Work Absence and Productivity	2007/07/01	English	81